Managers / Q1 2026
HBK INVESTMENTS L P
CIK 0001011443 · 2300 NORTH FIELD STREET, STE 2200, DALLAS, TX, 75201 · 2147586100
Summary
Hbk Investments L P reported $9.9B in U.S.-listed holdings across 346 positions for Q1 2026.
Its largest position, KEL, represents 8.4% of the portfolio.
Compared with Q4 2025, the fund opened 116 new positions and exited 83.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 80.0% · $10.6B
- Other · 9.1% · $1.2B
- ETP · 5.4% · $713M
- US DOMESTIC · 3.6% · $477M
- GLOBAL · 0.6% · $86M
- Other · 1.2% · $165M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| PENPENUMBRA INC | NEW | +1.63M | 1.63M | +$537M | $537M |
| MASI*MASIMO CORP | NEW | +2.58M | 2.58M | +$458M | $458M |
| CTRACOTERRA ENERGY INC | NEW | +10.57M | 10.57M | +$371M | $371M |
| SDASEALED AIR CORP NEW | NEW | +7.31M | 7.31M | +$307M | $307M |
| ACLXGBXARCELLX INC | NEW | +2.28M | 2.28M | +$262M | $262M |
| JANUS HENDERSON GROUP PLC | NEW | +4.23M | 4.23M | +$217M | $217M |
| 430TERNS PHARMACEUTICALS INC | NEW | +2.95M | 2.95M | +$156M | $156M |
| APLSUSDAPELLIS PHARMACEUTICALS INC | NEW | +3.55M | 3.55M | +$143M | $143M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2026
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $9.9B | 346 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025REVEALED | $15.1B | 273 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025REVEALED | $11.5B | 263 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $4.7B | 202 | Aug 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025REVEALED | $5.6B | 182 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024REVEALED | $7.3B | 194 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $6.3B | 154 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024REVEALED | $23.0B | 168 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024REVEALED | $25.0B | 175 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $18.5B | 194 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023REVEALED | $15.4B | 217 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023REVEALED | $19.9B | 387 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023REVEALED | $2.4B | 21 | May 15, 2023 | RESTATEMENT | changes · EDGAR ↗ |
| Q4 2022REVEALED | $14.9B | 301 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $11.7B | 393 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022REVEALED | $25.9B | 531 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $21.5B | 662 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021REVEALED | $29.0B | 714 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021REVEALED | $25.0B | 739 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021REVEALED | $23.9B | 804 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021REVEALED | $18.9B | 805 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020REVEALED | $12.8B | 673 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020REVEALED | $10.5B | 614 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020REVEALED | $7.3B | 551 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $3.3B | 499 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019REVEALED | $11.5B | 650 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $5.1B | 607 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019REVEALED | $8.3B | 590 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019REVEALED | $8.3B | 1,016 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $7.0B | 1,156 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.